Lipitor
Product Images NDC 54868-4934

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lipitor (NDC 54868-4934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 10 mg Package Label (3934)

FDA Label Image

Image Of 20 mg Package Label (3946)

FDA Label Image

Image Of 40 mg Package Label (4229)

FDA Label Image

Image Of 80 mg Package Label (4934)

FDA Label Image

Image Of Pfizer Logo (Pfizer)

Image Of Pfizer Logo (Pfizer)
This is a description of a distribution company called Parke-Davis, which is a division of Pfizer Inc. The company is based in New York, with a zip code of 10017. They distribute products or goods, although the specific type of product or service is not specified.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

FDA Label Image

Image Of Figure 1 (Figure 1)

FDA Label Image

Image Of Figure 2 (Figure 2)

Image Of Figure 2 (Figure 2)
The text appears to be a graph or chart with labels such as "Cumulative Hazard (%)" and "Time to First Primary Endpoint Through Four (4) Years of Followup (Years)". The chart compares the hazard rates of a medication called "Atorvastatin" to a placebo, with an associated Hazard Ratio (HR) of 0.53. Without the image of the chart or graph, it is difficult to provide a more specific description.*
FDA Label Image

Image Of Figure 3 (Figure 3)

Image Of Figure 3 (Figure 3)
The text describes the results of a study on the effectiveness of two drugs, Horvastatin 10 mg and Sorvastatin 80 mg, in reducing the occurrence of cardiovascular events in patients. The text highlights the percentage of subjects who experienced E vert, and it reports the Hazard Ratio (HR) and the p-value for the comparison between the two drugs. The text also includes a graph showing the time to the first major cardiovascular endpoint for the study subjects.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.